Skip to content
Condition

Medication-Overuse Headache

When the painkillers become the cause — the treatment that turns an occasional headache into a daily one

Last reviewed
July 2026
Version
1.0
Review cadence
Annually

What it is

Medication-overuse headache is a secondary headache disorder: a headache caused by the frequent use of the very medications taken to treat headache, in someone who already has an underlying headache disorder — usually migraine, sometimes tension-type headache. It is defined by the pattern rather than by any test: headache on 15 or more days a month, in a person overusing acute headache medication, developing or worsening as a consequence of that overuse. The mechanism the diagnosis captures is a trap that closes slowly. Someone with migraine or frequent tension headache takes an acute painkiller to treat each attack; as attacks become more frequent, the medication is used more often; and past a threshold, the frequent use itself begins driving the headache, so the person takes more, and the cycle tightens. The result is a near-daily, often dull, background headache that feels like a worsening of the original problem and is in fact partly created by its treatment. It is common — affecting roughly 1 to 2% of adults — and it is both preventable and treatable, which is the reason it is worth recognising rather than enduring.

Why it matters

This is one of the most under-recognised headache disorders, and its importance is out of proportion to how little it is discussed. It is common, it causes substantial disability, and — unusually among chronic headaches — it is often reversible: the headache frequently improves when the overused medication is reduced. The reason it goes unrecognised is built into how it feels. A person whose headaches are becoming more frequent reasonably takes their painkillers more often, and reasonably interprets the worsening as their underlying condition getting worse rather than as a consequence of the treatment. The escalation is logical from the inside and invisible without the right question, which is not 'how bad is your headache' but 'how many days a month do you take something for it'. The thresholds matter and are specific: the acute medications differ in how quickly they cause the problem, and the practical consequences of coming off them differ too. This page exists to name the pattern, to give the threshold that flips a treatment into a cause, and to be honest that getting out of the cycle is worth doing but is not always comfortable — and is a process to do with a clinician rather than alone.

The evidence

What BioSignal knows about treating this

Guideline-anchored clinical contextLast reviewed July 2026 · reviewed annually · 4 references

What works for Medication-Overuse Headache

BioSignal’s clinical summary, most important first.

  1. Recognising the pattern — the single most important and most missed step
  2. Reducing or stopping the overused acute medication — the core of treatment, and often enough on its own to improve the headache
  3. Doing the withdrawal with a clinician — because symptoms usually worsen transiently before they improve, and the approach (abrupt vs tapered, which drug) depends on what is being overused
  4. Starting appropriate preventive treatment for the underlying migraine or tension-type headache, so acute medication is needed less often
  5. Behavioural support and education — which the evidence supports as an adjunct to withdrawal
  6. Limiting future acute-medication days to stay under the threshold once recovered

Signal Records relevant to this condition

Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.

Start Here

New to this? Read these first

  1. FoundationBrain & Cognitive HealthThe best place to understand what actually protects the brain — and why most nootropics don't.
  2. Signal RecordNSAIDsIbuprofen, naproxen, diclofenac — and why there is no safe one
  3. Body SystemBrainCognition, mood, memory, and neurological health.
  4. ConditionMigraineA common, disabling neurological disorder
Typical Journey

How this usually unfolds

  1. Recognize risk factors
  2. Get diagnosed
  3. Track key biomarkers
  4. Lifestyle first
  5. Evidence-based treatment
  6. Long-term monitoring

An orientation to how this topic is typically approached — not medical advice.

Who is at risk

  • An underlying primary headache disorder — migraine most of all, then tension-type headache
  • Frequent use of acute headache medication — the central and necessary factor
  • Using medication types that cause the problem fastest: opioids, butalbital-containing combinations, and triptans reach the threshold at fewer days than simple analgesics
  • Higher baseline headache frequency
  • Anxiety, depression, and other biobehavioural factors

How it's diagnosed

Medication-overuse headache is diagnosed clinically, from the history and a normal neurological examination, using the International Classification of Headache Disorders (ICHD-3) criteria — there is no scan or blood test for it. The two things that make the diagnosis are a headache present on 15 or more days a month, and regular overuse, for more than three months, of one or more acute headache medications. The threshold for 'overuse' is medication-specific, and this is the detail most people have never been told: simple analgesics such as paracetamol or NSAIDs count as overuse at 15 or more days a month, while triptans, ergots, opioids, and combination analgesics count at 10 or more days a month — the second group causes the problem faster. The most useful diagnostic instrument is not a test but a headache diary that records both headache days and medication days, because the medication-day count is the number that identifies the disorder and the number people almost never track. An important honesty in the criteria: the diagnosis presumes an underlying primary headache disorder, so this is not a claim that ordinary short courses of painkillers for non-headache pain cause headaches — it is specifically about acute headache treatment in people who already get headaches.

  • The ICHD-3 pattern — headache on ≥15 days/month with regular acute-medication overuse for >3 months in someone with a primary headache disorder
  • A headache diary recording BOTH headache days and medication days — the medication-day count is the diagnostic number
  • The medication-specific threshold — ≥15 days/month for simple analgesics; ≥10 days/month for triptans, ergots, opioids, and combination analgesics
  • A normal neurological examination — the diagnosis is clinical, not radiological
  • Consideration of red flags that would indicate a different secondary headache
Most important

Key biomarkers

Biomarker pages for this condition are on the roadmap.

Day to day

Lifestyle

  • Count medication days, not just headache days — taking something for headache on more than about 10-15 days a month (depending on the drug) is the threshold that turns treatment into cause
  • Keep a diary that records what you took and when; the medication-day number is the one that reveals this disorder and the one nobody tracks
  • If your painkillers seem to be working less well and your headaches are getting more frequent, consider that the two might be connected rather than assuming your condition is worsening
  • Do not simply stop everything abruptly on your own — withdrawal often worsens the headache temporarily, and the right approach depends on which medication is involved
  • Ask about preventive treatment for the underlying headache disorder, because reducing attack frequency is what lets you stay under the threshold
  • Opioids and combination painkillers cause this fastest and are the ones to be most cautious about for headache
Explore

Explore this condition across BioSignal

Related Foundations

Related Signal Records

Related body systems

Frequently asked questions

Can taking painkillers actually cause headaches?

Yes — and this is the counter-intuitive fact the whole disorder turns on. Medication-overuse headache is a recognised secondary headache in which the frequent use of acute headache medication, in someone who already has a headache disorder, begins to drive the headache itself. The result is often a near-daily, dull background headache that feels exactly like the original problem getting worse. The pattern that gives it away is escalation: the painkillers seem to work less well, so they are taken more often, so the headaches become more frequent — a loop that is entirely logical from the inside and hard to see without counting medication days. It is common, affecting roughly 1 to 2% of adults, and it is under-recognised precisely because the sufferer and often the clinician read the worsening as the underlying condition deteriorating rather than as a consequence of its treatment. Two things are worth holding onto. This applies to people treating an existing headache disorder — it is not a claim that a short course of painkillers for a sprained ankle gives you headaches. And it is treatable: the headache frequently improves when the overused medication is reduced, which is the hopeful part of an otherwise frustrating diagnosis.

How many days a month is too many?

It depends on the medication, and the thresholds are specific enough to be worth memorising if you get headaches. For simple painkillers — paracetamol, or NSAIDs like ibuprofen and aspirin — overuse is defined as taking them on 15 or more days a month. For the stronger and faster-acting headache drugs — triptans (the migraine-specific medications), ergots, opioids, and combination painkillers that mix, say, paracetamol with codeine or caffeine — the threshold is lower, at 10 or more days a month, because these cause the problem faster. And 'days a month' is the unit that matters, not doses per day: it is the frequency of treatment days, sustained over more than three months, that defines the risk, not the amount taken on any single day. The practical takeaway is a number to watch: if you are taking any acute headache medication on more than about 10 days a month, and certainly 15, on a regular basis, you are in the zone where the treatment can start becoming the problem. That is not a reason to stop treating a bad attack — it is a reason to track your medication days and to talk to a clinician about prevention, so you need the acute drugs less often.

Which painkillers are the worst for this?

The ones with the lower threshold, and there is a clear hierarchy. Opioids (codeine, morphine-type drugs) and butalbital-containing combination painkillers are the worst offenders — they cause medication-overuse headache readily and are the drugs headache specialists most want to keep away from frequent headache treatment. Combination analgesics, which mix a painkiller with caffeine or codeine, and triptans and ergots, are the next tier, crossing into overuse at 10 or more days a month. Simple analgesics — plain paracetamol, or NSAIDs like ibuprofen — are the least likely to cause it, with the higher 15-day threshold, though they can still do so. This hierarchy has a practical implication that runs against a common instinct: reaching for something 'stronger' for frequent headaches often means reaching for exactly the drugs most likely to entrench the problem. If you are treating headaches often, the safer acute options are the simple analgesics, and the real answer to frequent headaches is not a stronger acute drug but effective prevention of the underlying disorder — which is a conversation worth having before the cycle sets in.

How do I get out of the cycle?

By reducing the overused medication — which is the core of treatment and is genuinely effective — but doing it with support, because the honest part is that it usually gets worse before it gets better. When the overused drug is withdrawn, there is typically a period of increased headache, sometimes with nausea, restlessness, and poor sleep, lasting days to a couple of weeks before improvement comes. That transient worsening is the single biggest reason people abandon the attempt and conclude they cannot manage without the medication — which is exactly the misreading that keeps the cycle going. How the withdrawal is done — abruptly or tapered, as an outpatient or, rarely, with more support — depends on which medication is being overused (opioids and butalbital, for instance, are not drugs to stop carelessly), which is one reason this is a process to do with a clinician rather than alone. Two things make it work better: starting a preventive treatment for the underlying migraine or tension-type headache so that acute medication is needed less, and behavioural support, which the evidence backs as a useful adjunct. What the evidence does NOT clearly support is adding routine preventive steroids or choosing inpatient over outpatient withdrawal as a general rule — a systematic review found no clear benefit from those. The reliable ingredient is reducing the overused drug; the rest is individual.

Is this the same as being addicted to painkillers?

No, and the distinction matters for the same reason it did with other medications: conflating the two adds shame to a problem that is already hard enough. Medication-overuse headache is a pharmacological and physiological phenomenon — frequent acute treatment of headache changing how the pain system behaves — not, in itself, a substance-use disorder. Most people who develop it are taking medication as they understood they should, to treat real pain, and escalating in a way that made sense at each step. That said, the honest complication is that some of the medications involved — opioids and butalbital-containing combinations in particular — genuinely can produce dependence and are drugs of misuse, so the two problems can coexist, and that is part of why stopping those specific drugs needs care and clinical support rather than willpower. But the core disorder is not a moral failing or an addiction: it is a treatable consequence of treating headaches often, and the framing that helps is that the medication stopped being the solution and quietly became part of the problem — which is a reason to change the approach, not to feel judged for having followed it.

When should a headache be checked rather than medicated?

When it is new, changing, or carries warning features — because medication-overuse headache is a diagnosis made in people with an established headache disorder, and a headache that does not fit that story needs assessing rather than treating. Seek urgent care for a headache that is sudden and severe or the worst of your life, a headache with fever and a stiff neck, a headache with weakness, numbness, difficulty speaking, or visual loss, or a headache after a head injury. Seek prompt assessment for a new headache after age 50, a headache that has changed its pattern or is progressively worsening, a headache in someone with cancer or a suppressed immune system, or a new or severe headache in pregnancy or after birth. Those features point away from a primary headache disorder and its overuse complication and toward something that needs investigation. For the person who already knows their migraine or tension headache and is simply finding they treat it more and more often, the issue is usually not danger but the cycle this page describes — and the right response to that is counting medication days and seeing a clinician about prevention, not taking more.

Evidence summary

Medication-overuse headache (MOH) is a secondary headache disorder defined by ICHD-3 as headache on ≥15 days/month developing or worsening from regular overuse, for >3 months, of acute headache medication in a person with a pre-existing primary headache disorder — usually migraine or tension-type headache. It affects roughly 1-2% of adults, causes substantial disability, and is both under-recognised and, importantly, often reversible. The overuse threshold is medication-specific: ≥15 days/month for simple analgesics (paracetamol, NSAIDs) and ≥10 days/month for triptans, ergots, opioids and combination analgesics, which entrain the disorder faster; opioids and butalbital-containing combinations are the highest-risk agents. Diagnosis is clinical with a normal neurological examination; a headache diary recording medication days — not merely headache days — is the key instrument, because the medication-day count is what identifies the disorder and is rarely tracked. The mechanism involves altered descending pain modulation and central sensitisation. The core of treatment is withdrawal of the overused medication, which frequently improves the headache and is often sufficient on its own; withdrawal is typically accompanied by transient worsening (increased headache, nausea, restlessness) over days to weeks, which is the main driver of treatment abandonment. A systematic review of MOH treatments found the reliable element to be reduction of the overused drug, with no clear benefit demonstrated for routine prophylactic prednisone versus placebo or for inpatient over outpatient withdrawal; concurrent initiation of preventive treatment for the underlying disorder and behavioural support (RCT-supported as an adjunct to withdrawal) improve outcomes. The diagnosis presumes an underlying headache disorder and does not imply that short analgesic courses for non-headache pain cause headache. This page covers MOH; migraine, tension-type headache and cluster headache are separate published Conditions, and red-flag or new headaches fall outside it and are guarded.

References & sources

  • Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers 2023;9(1):5 (PMID 36732518; DOI 10.1038/s41572-022-00415-0)
  • Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211 (PMID 29368949; DOI 10.1177/0333102417738202)
  • de Goffau MJ, Klaver ARE, Willemsen MG, Bindels PJE, Verhagen AP. The effectiveness of treatments for patients with medication overuse headache: a systematic review and meta-analysis. J Pain 2017;18(6):615-627 (PMID 28007591; DOI 10.1016/j.jpain.2016.12.005)
  • Pijpers JA, Kies DA, van Zwet EW, et al. Behavioural intervention in medication overuse headache: a concealed double-blind randomised controlled trial. Eur J Neurol 2022;29(5):1496-1504 (PMID 35064733; DOI 10.1111/ene.15256)

Educational information — not medical advice

Condition pages orient you across the evidence; they don't diagnose or treat. Diagnosis and management belong with a qualified clinician. See our Medical Disclaimer.

Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.

Give feedback